Update-Moody's: M&A among generic drug makers raises risk for investors

Reuters

Teva Pharmaceutical Industries Ltd, Mylan Inc. , Actavis plc and Sandoz

For the full text of this story please click the following link:

http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_295755&WT.mc_id=NLTITLE_YYYYMMDD_PR_295755

View Comments (0)